Search research articles
Contact Us
Filters
Showing results (711-720 of 721) with videos related to
Page
of 73
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 11, 2025
Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancer
P Harter, F Trillsch, A Okamoto, et al.
Gynecologic Oncology
|
November 12, 2024
Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)
Matthew A Powell, David Cibula, David M O'Malley, et al.
JAMA Surgery
|
July 2, 2025
Rizedisben in Minimally Invasive Surgery: A Nonrandomized Clinical Trial
Samuel A Gold, Maria M Pere, Melissa Assel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2024
Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial
M A Powell, L Bjørge, L Willmott, et al.
The New England Journal of Medicine
|
March 27, 2023
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Mansoor R Mirza, Dana M Chase, Brian M Slomovitz, et al.
Therapeutic Advances in Medical Oncology
|
October 14, 2025
A plain language summary publication of patients' survival with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel
Matthew A Powell, Line Bjørge, Lyndsay Willmott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 2023
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
Shannon N Westin, Kathleen Moore, Hye Sook Chon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 13, 2021
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Apar Kishor P Ganti, Billy W Loo, Michael Bassetti, et al.
Journal of Lower Genital Tract Disease
|
September 28, 2017
Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States
Nicolas Wentzensen, L Stewart Massad, Edward J Mayeaux, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 11, 2026
NCCN Guidelines® Insights: Small Cell Lung Cancer, Version 2.2026
Apar Kishor P Ganti, Billy W Loo, Shahed Badiyan, et al.
Page
of 73
Search research articles
Search
Showing results (711-720 of 721) with videos related to
Sort By:
Page
of 73
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 11, 2025
Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancer
P Harter, F Trillsch, A Okamoto, et al.
Gynecologic Oncology
|
November 12, 2024
Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)
Matthew A Powell, David Cibula, David M O'Malley, et al.
JAMA Surgery
|
July 2, 2025
Rizedisben in Minimally Invasive Surgery: A Nonrandomized Clinical Trial
Samuel A Gold, Maria M Pere, Melissa Assel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2024
Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial
M A Powell, L Bjørge, L Willmott, et al.
The New England Journal of Medicine
|
March 27, 2023
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Mansoor R Mirza, Dana M Chase, Brian M Slomovitz, et al.
Therapeutic Advances in Medical Oncology
|
October 14, 2025
A plain language summary publication of patients' survival with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel
Matthew A Powell, Line Bjørge, Lyndsay Willmott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 2023
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
Shannon N Westin, Kathleen Moore, Hye Sook Chon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 13, 2021
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Apar Kishor P Ganti, Billy W Loo, Michael Bassetti, et al.
Journal of Lower Genital Tract Disease
|
September 28, 2017
Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States
Nicolas Wentzensen, L Stewart Massad, Edward J Mayeaux, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 11, 2026
NCCN Guidelines® Insights: Small Cell Lung Cancer, Version 2.2026
Apar Kishor P Ganti, Billy W Loo, Shahed Badiyan, et al.
Page
of 73